The first participants received shots in a 30,000-person trial of an experimental vaccine being developed by biotech company Moderna in partnership with the U.S. government.

Two coronavirus vaccines begin the last phase of testing: 30,000-person trials - The Washington Post

SOURCE: The Washington Post

Click here to READ THE FULL STORY.